| PERIOD ENDING | 22-Feb-09 | 23-Nov-08 | 24-Aug-08 | 25-May-08 | | Total Revenue | 3,537,400 | 4,010,900 | 3,497,300 | 3,471,100 | | Cost of Revenue | 2,259,900 | 2,791,200 | 2,305,600 | 2,438,900 | | | Gross Profit | 1,277,500 | 1,219,700 | 1,191,700 | 1,032,200 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 671,000 | 729,400 | 719,400 | 698,300 | | Non Recurring | 1,200 | (126,300) | 2,700 | (1,300) | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 605,300 | 616,600 | 469,600 | 335,200 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 700 | 2,900 | 7,900 | (13,800) | | Earnings Before Interest And Taxes | 606,000 | 621,600 | 475,400 | 341,100 | | Interest Expense | 101,100 | 103,500 | 94,500 | 95,800 | | Income Before Tax | 504,900 | 518,100 | 380,900 | 245,300 | | Income Tax Expense | 231,700 | 173,100 | 133,200 | 91,200 | | Minority Interest |
-
| 2,100 | (2,100) | 19,700 | | | | Net Income From Continuing Ops | 288,900 | 378,200 | 278,500 | 185,200 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 288,900 | 378,200 | 278,500 | 185,200 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $288,900 | $378,200 | $278,500 | $185,200 |
|
0.45% Nasdaq 
0.20%
Income Statement
